Mutual Quinine Approved For Malaria; Unapproved Versions Could Be Pulled

FDA will hold an internal meeting in early September to discuss the fate of unapproved quinine products on the market following its first NDA approval for quinine sulfate to treat malaria

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet